Pages

▼
Showing posts with label AL Amyloid. Show all posts
Showing posts with label AL Amyloid. Show all posts
01 December, 2019

#amyloidosisjc 12-1-19: MRD and AL #amyloidosis

›
Here is a synopsis of the article we will be discussing in the December 1st, 2019 session of #amyloidosisJC, an online journal club focusin...
19 June, 2019

#amyloidosisJC 6/19/19: light chain stabilization and AL #amyloidosis

›
In this round of #AmyloidosisJC, we will be discussing a basic science paper that describes small molecules that stabilize light chain prot...
1 comment:
08 May, 2019

#AmyloidosisJC 5/8/19: ASCT in AL patients with impaired renal function

›
In this installment of #amyloidosisJC we will be discussing outcomes of Autologous Stem Cell Transplant (ASCT) in AL amyloidosis patients wh...
02 November, 2018

#amyloidosisJC 11/4/18: Daratumumab as therapy for AL amyloidosis

›
We will be discussing this short, sweet, yet practice-changing article demonstrating the significant therapeutic efficacy of daratumumab in...
21 February, 2016

Leaping back into #amyloidosisJC on Monday 2/29/16 at 9 pm EST: ICD placement for cardiac #amyloidosis

›
#amyloidosisJC returns at 9 pm EST on Monday February 29th 2016 with a discussion focusing on the role of implanted cardiac defibrillators ...
30 November, 2015

#amyloidosisJC 12/1/2015: A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.

›
This is the 5th and final pre- symposium installment of #amyloidosisJC, with the following summary by travel grant awardee and article a...